Oligo Name | Ordered by... | Length | Sequence | Description | ||
Pimer forward CAT | Sigma | 64 | GATCGCAATTGACCAACAAGGAGAAATCTAGATGGCCGGCGAGAAAAAAATCACTGGATATACC | designed to get CAT-gene + Freigem restriction sites out of the lab vector no 258 | ||
Primer reverse CAT | Sigma | 58 | GTGGCAGGGCGGGGCGACCGGTTAATACTAGTAGCGGCCGCCTGCAGAAGCTTGGGTA | designed to get CAT-gene + Freigem restriction sites out of the lab vector no 258 | ||
Short Linker | Sigma | 18 | CTAGAGGTGGTTCTGGTA | GlySerGlyGly | ||
Middle Linker | Sigma | 30 | CTAGAGGTGGTTCTGGTACTAGAGGTGGTTCTGGTA | GlySerGlyGlyx2 | ||
Long Linker | Sigma | 42 | CTAGAGGTGGTTCTGGTACTAGAGGTGGTTCTGGTACTAGAGGTGGTTCTGGTA | GlySerGlyGlyx3 | ||
Primer forward GenIII | Sigma | 52 | GAATTCGCGGCCGCTTCTAGATGGCCGGCGATTTTGATTATGAAAAGATGGC | Insert of GenIII(restriction sites RFC25) into M13DNA , | ||
Primer reverse GenIII | Sigma | 53 | CTGCAGGCGGCCGCTACTAGTATTAACCGGTAGACTCCTTATTACGCAGTATG | Insert of GenIII(restriction sites RFC25) into M13DNA , | ||
A4 AGO | Sigma | 21 | AAGTTTTTTGGGGTCGAGGTG | guide oligo complentary to target sequenz, the cutting event will be done after the tenth base 5'3' | ||
A1 AGO | Sigma | 21 | ACAACCATCGCCCACGCATAA | guide oligo complentary to target sequenz, the cutting event will be done after the tenth base 5'3'.The M13ssDNA will be cut at position 3100 | ||
A2 AGO | Sigma | 21 | GGTTTTACTCTGATTCTCTTC | guide oligo complentary to target sequenz, the cutting event will be done after the tenth base of the oligo 5'3'.The M13ssDNA will be cut at position 550. | ||
A3 AGO | Sigma | 21 | TACCTTCGGGTACTCTTCTAA | guide oligo complentary to target sequenz, the cutting event will be done after the tenth base 5'3'.The M13ssDNA will be cut at position 1280. | ||
A5_Ago_pETfragment | Sigma | 21 | AAGTTTTTTGGGGTCGAGGTG | guide oligo complentary to target sequenz, the cutting event will be done after the tenth base 5'3'.The M13ssDNA will be cut at position 100 | ||
Aa BB Primer Middle a | Sigma | 50 | TCGTTCATTTTGAAATCCCCTGAACTCTTCTTCACCCACTCTTTTCAGTT | deleted EcoRI site | ||
Aa BB Primer Middle b | Sigma | 50 | GGAAGGTGATATTATGTACTGGCTTTAATAATACTAGTAGCGGCCGCTGCAG | deleted EcoRI site | ||
Aa BB Primer Start | Sigma | 45 | GGTTTAAAAGAGCTTCCTTTCCCATCTAGAAGCGGCCGCGAATTC | Addon Tail to add Biobrick prefix | ||
Aa BB Primer Back | Sigma | 52 | AACTGAAAAGAGTGGGTGAAGAAGAGTTCAGGGGATTTCAAAATGAACGA | Addon Tail to add Biobrick suffix | ||
AGO-target _M13 | Sigma | 60 | CTGCAAGCCTCAGCGACCGAATATATCGGTTATGCGTGGGCGATGGTTGTTGTCATTGTC | 5'biotinylated olgio for phage display | ||
AGO-guide-A1 5' Phos | Sigma | 21 | [Phos]ACAACCATCGCCCACGCATAA | phosporilised(5') for phage display assay with AGO protein | ||
AGO-guide-A4 5' Phos | Sigma | 21 | [Phos]AAGTTTTTTGGGGTCGAGGTG | phosporilised(5') for phage display assay with AGO protein | ||
Fok control 1 | Sigma | 40 | TTCTACTAATAGTAGTAGCATTAACATCCAATAAATCATA | 1669bp for the bond of gel elctrophoresis , the oligo hybridisized to the ssDNA enable Fok to cut | ||
Fok control 2 | Sigma | 40 | GTCATTTTTGCGGATGGCTTAGAGCTTAATTGCTGAATAT | 1914bp for the bond of gel elctrophoresis, the oligo hybridisized to the ssDNA enable Fok to cut | ||
Fok control 3 | Sigma | 40 | TGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGT | 786bp for the bond of gel elctrophoresis,the oligo hybridisized to the ssDNA enable Fok to cut | ||
5'fluo40bp | Sigma | 40 | Test nucleotide for the in vivo assay | |||
xbaI_RBS-Strep-Fok_a | Sigma | 40 | GCTCTAGAGAAGGAGATATACTATGGCCGGCTGGAGCCAT | Insert a RBS befor the StrepTag | ||
StrepFoka_r | Sigma | 28 | GAAGCTTCTGCAGCGGCCGCTACTAGTA | Insert a RBS befor the StrepTag | ||
XbaI_DsbAss_AgeI_2r | Sigma | 62 | CCGGTCGCCGATGCGCTAAACGCTAAAACTAAACCAGCCAGCGCCAGCCAAATCTTTTTCAT | olgio with xbaI and ageI ends , can linked on DsbA signalsequenz | ||
pBAD-TOPO f | Sigma | 34 | GTCCCCCCGGGAACCCCGCTTATTAAAAGCATTC | add-on tail primer for pcr to remove the two AgeI sites of the vector and to introduce the bb-pre and suffix | ||
pBAD-TOPO r | Sigma | 56 | TCCCCCCGGGCTGCAGTATGAATTCACTCCTTCTTAAAGTTAAACAAAATTATTTC | add-on tail primer for pcr to remove the two AgeI sites of the vector and to introduce the bb-pre and suffix | ||
XbaI_NgoMIV_DsbA forward | Sigma | 19 | CGCTTCTAGATGGCCGGCA | add-on tail primer to generte a FOS-DsbA-Split-Fok_a part | ||
DsbA-Fos | Sigma | 36 | CGTTTAGCGCATCGGCGCACCATCACCACCACCATG | add-on tail primer to generte a FOS-DsbA-Split-Fok_a part | ||
Fos-SplitFok_a | Sigma | 38 | GGAGTTCATCCTGGCAGCACGACCAGCCTGTAAGATTC | add-on tail primer to generte a FOS-DsbA-Split-Fok_a part | ||
SplitFok_a age_Spe_not_pst | Sigma | 17 | AGCTCTGCAGCGGCCGC | add-on tail primer to generte a FOS-DsbA-Split-Fok_a part | ||
80mer Fok control | Sigma | 80 | AGTTCGGTTCCCTTATGATTGACCGTCTGCGCCTCGTTCCGGCTAAGTAACATGGAGCAGGTCGCGGATTTCGACACAAT | target oligonucleotide for Fok cleavage assay | ||
80mer Fok control | Sigma | 80 | [Cy3]AGTTCGGTTCCCTTATGATTGACCGTCTGCGCCTCGTTCCGGCTAAGTAACATGGAGCAGGTCGCGGATTTCGACACAAT | target oligonucleotide for Fok cleavage assay with fluorescine mark | ||
Standard 35 forward | Sigma | 25 | CCGAATTCGCGGCCGCTTCTAGATG | freiburg stadard primer (standard 25) to amplify insert | ||
Standard 35 reverse | Sigma | 29 | GCTCTGCAGCGGCCGCTACTAGTATTAAC | freiburg stadard primer (standard 25) to amplify insert | ||
pr_fwd_Xba_SDII_TorA | Sigma | 55 | ATATAAATTCTAGATAACGAGGGCAAATCATGAACAATAACGATCTCTTTCAGGC | Shine-Dalgarno sequence II TorA(signal sequence for periplasm transport) | ||
ssDNA_prod_pET39b+ | Sigma | 23 | CGGATCCGATATCGCCATGGTTG | primer for modifies thermocycler protocoll to produce ssDNA | ||
fokm_li_xbaI_ageI | Sigma | 90 | CTAGATGGCCGGCGGTTCTGGTGGTGGTTCTGGCGGTGGTTCTGGAGGTAGTTCTGGCGGTGGATCTGGAGGCGGTTCTGGGTCAGGATC | 36 GS linker wrong | ||
fok_m_link_NgoMIV_HINFI_compl | Sigma | 91 | CCGGCGGTGGTTCTGGTGGTGGTTCTGGCGGTGGTTCTGGAGGTAGTTCTGGCGGTGGATCTGGAGGCGGTTCTGGGTCAGGATCTGGTGATGGTTCTGGCTCTGGG | 36 Gs linker wrong complement | ||
o_diA1_5dig_site1 | Purimex | 16 | CGGAACGAGGCGCAGA | Modified oligonucleotid to guide the Fok-Complex to the target sequence via digoxigenin | ||
o_diAB1_5fluo_site1 | Purimex | 16 | CGGTCAATCATAAGGG | Modified oligonucleotid to guide the Fok-Complex to the target sequence via fluorescin | ||
o_diB1_15dig_site1 | Purimex | 30 | CCATGTTACTTAGCCGGAACGAGGCGCAGA | Modified oligonucleotid to guide the Fok-Complex to the target sequence via digoxigenin | ||
o_mono1_3fluo_14dig_site1 | Purimex | 30 | CATGTTACTTAGCCGGAACGAGGCGCAGAC | Modified oligonucleotid to guide the Fok-Complex to the target sequence via digoxigenin and fluorecine |
Team:Freiburg bioware/oligos
From 2009.igem.org
(Difference between revisions)
(New page: <div style="overflow:scoll"><table x:str border=0 cellpadding=0 cellspacing=0 width=2025 class=xl658166 style='border-collapse:collapse;table-layout:fixed;width:1519pt'> <col class=xl658...) |
|||
(3 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | <div style="overflow: | + | <html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" |
+ | dir="ltr" lang="en-US"> | ||
+ | <head> | ||
+ | <meta http-equiv="Content-Type" | ||
+ | content="text/html; charset=UTF-8" /> | ||
+ | <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" /> | ||
+ | <title>FREiGEM</title> | ||
+ | <script type="text/javascript" src="script.js"></script> | ||
+ | <style id="Kopie von Xl0000002_8166_Styles"> | ||
+ | <!--table | ||
+ | {mso-displayed-decimal-separator:"\,"; | ||
+ | mso-displayed-thousand-separator:"\.";} | ||
+ | .font58166 | ||
+ | {color:black; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0;} | ||
+ | .font68166 | ||
+ | {color:green; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:700; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0;} | ||
+ | .font78166 | ||
+ | {color:red; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:700; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0;} | ||
+ | .xl658166 | ||
+ | {padding-top:1px; | ||
+ | padding-right:1px; | ||
+ | padding-left:1px; | ||
+ | mso-ignore:padding; | ||
+ | color:black; | ||
+ | font-size:11.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0; | ||
+ | mso-number-format:General; | ||
+ | text-align:center; | ||
+ | vertical-align:bottom; | ||
+ | mso-background-source:auto; | ||
+ | mso-pattern:auto; | ||
+ | white-space:nowrap;} | ||
+ | .xl668166 | ||
+ | {padding-top:1px; | ||
+ | padding-right:1px; | ||
+ | padding-left:1px; | ||
+ | mso-ignore:padding; | ||
+ | color:black; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0; | ||
+ | mso-number-format:General; | ||
+ | text-align:center; | ||
+ | vertical-align:bottom; | ||
+ | mso-background-source:auto; | ||
+ | mso-pattern:auto; | ||
+ | white-space:nowrap;} | ||
+ | .xl678166 | ||
+ | {padding-top:1px; | ||
+ | padding-right:1px; | ||
+ | padding-left:1px; | ||
+ | mso-ignore:padding; | ||
+ | color:black; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:400; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0; | ||
+ | mso-number-format:"\@"; | ||
+ | text-align:center; | ||
+ | vertical-align:bottom; | ||
+ | mso-background-source:auto; | ||
+ | mso-pattern:auto; | ||
+ | white-space:nowrap;} | ||
+ | .xl688166 | ||
+ | {padding-top:1px; | ||
+ | padding-right:1px; | ||
+ | padding-left:1px; | ||
+ | mso-ignore:padding; | ||
+ | color:green; | ||
+ | font-size:8.0pt; | ||
+ | font-weight:700; | ||
+ | font-style:normal; | ||
+ | text-decoration:none; | ||
+ | font-family:Calibri, sans-serif; | ||
+ | mso-font-charset:0; | ||
+ | mso-number-format:General; | ||
+ | text-align:center; | ||
+ | vertical-align:bottom; | ||
+ | mso-background-source:auto; | ||
+ | mso-pattern:auto; | ||
+ | white-space:nowrap;} | ||
+ | --> | ||
+ | </style> | ||
+ | |||
+ | <link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style.css&action=raw&ctype=text/css" | ||
+ | type="text/css" media="screen" /> | ||
+ | <!--[if IE 6]><link rel="stylesheet" href="style.ie6.css" type="text/css" media="screen" /><![endif]--><!--[if IE 7]><link rel="stylesheet" href="/wiki/index.php?title=User:Maximi/new_general_style_ie7.css&action=raw&ctype=text/css" type="text/css" media="screen" /><![endif]--> | ||
+ | </head> | ||
+ | <body> | ||
+ | <div id="art-page-background-simple-gradient"> </div> | ||
+ | <div id="art-main"> | ||
+ | <div class="art-Sheet"> | ||
+ | <div class="art-Sheet-tl"></div> | ||
+ | <div class="art-Sheet-tr"></div> | ||
+ | <div class="art-Sheet-bl"></div> | ||
+ | <div class="art-Sheet-br"></div> | ||
+ | <div class="art-Sheet-tc"></div> | ||
+ | <div class="art-Sheet-bc"></div> | ||
+ | <div class="art-Sheet-cl"></div> | ||
+ | <div class="art-Sheet-cr"></div> | ||
+ | <div class="art-Sheet-cc"></div> | ||
+ | <div class="art-Sheet-body"> | ||
+ | <div class="art-Header"> | ||
+ | <div class="art-Header-jpeg"></div> | ||
+ | </div> | ||
+ | <div class="art-nav"> | ||
+ | <div class="l"></div> | ||
+ | <div class="r"></div> | ||
+ | <ul class="art-menu"> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware"><span class="l"></span><span | ||
+ | class="r"></span><span class="t">Home</span></a></li> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team"><span | ||
+ | class="l"></span><span class="r"></span><span | ||
+ | class="t">The Team</span></a> | ||
+ | <ul> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team">Overview</a></li> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Team/Portraits">Portraits</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Project"><span class="l"></span><span | ||
+ | class="r"></span><span class="t">The | ||
+ | Project</span></a><ul> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Summary">Summary</a> | ||
+ | </li> | ||
+ | |||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Project#Highlights">Highlights</a></li> | ||
+ | </ul></li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice"><span | ||
+ | class="l"></span><span class="r"></span><span | ||
+ | class="t">Human | ||
+ | Practice</span></a> | ||
+ | <ul> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Ethics">Ethics</a> | ||
+ | </li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Human_Practice/Safety">Safety</a></li> | ||
+ | </ul> | ||
+ | |||
+ | </li> | ||
+ | <li><a href="https://2009.igem.org/Team:Freiburg_bioware/Notebook"><span class="l"></span><span | ||
+ | class="r"></span><span class="t">Notebook</span></a></li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/cloning1"class="active"><span | ||
+ | class="l"></span><span class="r"></span><span | ||
+ | class="t">Parts</span></a><ul> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/cloning1">Basic | ||
+ | Parts</a></li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/cloning">Composite | ||
+ | Parts</a></li> | ||
+ | </ul></li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Collaboration"><span | ||
+ | class="l"></span><span class="r"></span><span | ||
+ | class="t">Collaboration</span></a></li> | ||
+ | <li><a | ||
+ | href="https://2009.igem.org/Team:Freiburg_bioware/Modeling"><span | ||
+ | class="l"></span><span class="r"></span><span | ||
+ | class="t">Modeling</span></a></li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | <div class="art-contentLayout"> | ||
+ | <div class="art-content"> | ||
+ | <div class="art-Post"> | ||
+ | <div class="art-Post-tl"></div> | ||
+ | <div class="art-Post-tr"></div> | ||
+ | <div class="art-Post-bl"></div> | ||
+ | <div class="art-Post-br"></div> | ||
+ | <div class="art-Post-tc"></div> | ||
+ | <div class="art-Post-bc"></div> | ||
+ | <div class="art-Post-cl"></div> | ||
+ | <div class="art-Post-cr"></div> | ||
+ | <div class="art-Post-cc"></div> | ||
+ | <div class="art-Post-body"> | ||
+ | <div class="art-Post-inner"> | ||
+ | <div class="art-PostMetadataHeader"> | ||
+ | <a name="1"></a> | ||
+ | <h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> Oligonucleotides<span | ||
+ | class="art-PostHeader"></span> </h2> | ||
+ | </div> | ||
+ | <div style="overflow:scroll; width:100%;"><table x:str border=0 cellpadding=0 cellspacing=0 width=2025 class=xl658166 | ||
style='border-collapse:collapse;table-layout:fixed;width:1519pt'> | style='border-collapse:collapse;table-layout:fixed;width:1519pt'> | ||
<col class=xl658166 width=183 style='mso-width-source:userset;mso-width-alt: | <col class=xl658166 width=183 style='mso-width-source:userset;mso-width-alt: | ||
Line 544: | Line 756: | ||
<![endif]> | <![endif]> | ||
</table></div> | </table></div> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | <div class="cleared"></div> | ||
+ | <div class="art-Footer"> | ||
+ | <div class="art-Footer-inner"> | ||
+ | <div class="art-Footer-text"> | ||
+ | <p>contact: <a | ||
+ | href="mailto:freigem09@googlemail.com">freigem09@googlemail.com</a><br /> | ||
+ | </p> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="art-Footer-background"></div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </body> | ||
+ | </html> |
Latest revision as of 02:40, 22 October 2009